Fabienne Hermitte

How basal are triple‐negative breast cancers?

François Bertucci, Pascal Finetti, Nathalie Cervera et al. · International Journal of Cancer · 2008 · 433 citations · Full text

Basal Bcs, Breast Oncology, Engineering +14

Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

Daniela Cilloni, Aline Renneville, Fabienne Hermitte et al. · Journal of Clinical Oncology · 2009 · 430 citations · Full text

Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study

Franck Pagès, Thierry André, Déwi Vernerey et al. · Annals of Oncology · 2020 · 151 citations · Full text

Medicine, Cancer Management, Immunology +7

Identification and validation of an ERBB2 gene expression signature in breast cancers

François Bertucci, N. Borie, Christophe Ginestier et al. · Oncogene · 2004 · 132 citations

Radiation Oncology, Breast Oncology, Engineering +11

Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer

Florence Marliot, Xiaoyi Chen, Amos Kirilovsky et al. · Journal for ImmunoTherapy of Cancer · 2020 · 74 citations · Full text